Rhabdomyosarcoma differential diagnosis: Difference between revisions
Line 241: | Line 241: | ||
* FH | * FH | ||
| colspan="2" |Ultrasound: | | colspan="2" |Ultrasound: | ||
* Different appearance from solid to mixed cystic or solid to cystic | |||
Different appearance from solid to mixed cystic or solid to cystic | |||
CT scan: | CT scan: | ||
* Large and heterogenous | |||
Large and heterogenous | * Calcification | ||
* Necrosis | |||
Calcification | * Cystic changes | ||
MRI (in extra adrenal tumors): | |||
Necrosis | |||
Cystic changes | |||
MRI: | |||
T1: | T1: | ||
* Heterogenous enhancement | |||
Heterogenous enhancement | * Hypointense | ||
Hypointense | |||
T2: | T2: | ||
* Hyperintense | |||
Hyperintense | |||
T1 C+ (Gd): | T1 C+ (Gd): | ||
* Heterogenous enhancement | |||
Heterogenous enhancement | |||
| | | | ||
* Zellballen pattern on microscopy | * Zellballen pattern on microscopy | ||
Line 279: | Line 264: | ||
* Neurospecific enolase markers for neuronal cells | * Neurospecific enolase markers for neuronal cells | ||
* S-100 protein for sustentacular cells | * S-100 protein for sustentacular cells | ||
|- | |||
|Pediatric osteosarcoma<ref name="pmid8000997">{{cite journal| author=Dorfman HD, Czerniak B| title=Bone cancers. | journal=Cancer | year= 1995 | volume= 75 | issue= 1 Suppl | pages= 203-10 | pmid=8000997 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8000997 }}</ref> | |||
| | |||
* The second most common primary bone tumor | |||
* The third most common tumor among adolescents | |||
* Can be primary or secondary | |||
* Primary osteosarcoma occurs in age of 10-20 years old | |||
* Secondary osteosarcoma occurs in older patients and is secondary to paget disease and bone infarcts | |||
* Accompanied with positive history of trauma | |||
| + | |||
| + | |||
| | |||
* Soft tissue swelling | |||
* Fracture | |||
* Night sweating | |||
| + | |||
| | |||
* Mass swelling | |||
* Fever | |||
* Arthritis | |||
* Decreased joint range of motion | |||
* Lymphadenopathy | |||
| | |||
* N/A | |||
| colspan="2" |Plain radiography: | |||
* Osteolytic/ osteoblastic feature | |||
* Periosteum reaction | |||
* Calcification or ossification | |||
CT scan: | |||
* Primary lesion and chest CT are required | |||
* Demonstrate tumor location and extension | |||
MRI: | |||
* Exact assessment of tumor extension | |||
* Involving joint to joint findings | |||
| | |||
* Contain various cellular pleomorphism and mitoses | |||
* Poorly trabecular bone formation | |||
* Fibrocystic and chondroblastic features | |||
|- | |- | ||
|[[Burkitt's lymphoma|Burkitt lymphoma]] | |[[Burkitt's lymphoma|Burkitt lymphoma]] |
Revision as of 15:56, 27 February 2019
Rhabdomyosarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Rhabdomyosarcoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Rhabdomyosarcoma differential diagnosis |
Risk calculators and risk factors for Rhabdomyosarcoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Rhabdomyosarcoma must be differentiated from Ewing sarcoma, Lymphadenopathy, Neuroblastoma, Liposarcoma Osteosarcoma, Lymphoprofilerative disorders. Rhabdomyosarcoma of the orbit must be differentiated from other causes of orbital masses such as orbital pseudotumor, orbital tumors, orbital abscess, and vascular lesions.
Differential Diagnosis
- Rhabdomyosarcoma must be differentiated from following diseases:
Disease | History/demography | Symptoms | Physical examination | Diagnosis | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Palpable mass | Pain | Others | Mass tenderness | Others | Genetics | Imaging | Histology | ||||
Rhabdomyosarcoma[1][2][3][4] |
|
+ | + |
|
+/- |
|
Mutations in: |
CT scan:
Ultrasound:
MRI:
|
| ||
Wilms tumor[5][6][7][8][9] |
|
+ | + |
|
+/- |
|
Present mutations of:
|
Ultrasound:
CT scan:
|
| ||
Ewing sarcoma[10][11][12][13] |
|
+ | + | Weight loss/ fatigue | + |
|
|
Plain radiographic of region:
CT scan:
MRI:
|
| ||
Pediatric neuroblastoma [14][15][16][17] |
Age distribution:
|
+ (Abdominal) |
+ |
|
+ (Abdominal) |
|
|
CT scan:
MRI: T1:
T2:
C+ (Gd):
|
| ||
Pediatric pheochromocytoma[18][19][20][21] |
|
- | +/- |
|
- |
|
Genetic mutation in:
|
Ultrasound:
CT scan:
MRI (in extra adrenal tumors): T1:
T2:
T1 C+ (Gd):
|
Positive stains for:
| ||
Pediatric osteosarcoma[22] |
|
+ | + |
|
+ |
|
|
Plain radiography:
CT scan:
MRI:
|
| ||
Burkitt lymphoma | +/- (in non-endemic or sporadic form of the disease) | - | - | - | - |
|
|
| |||
Hydronephrosis | + | +/- | - | - | + (CVA tenderness in case of pyelonephritis) |
|
|
| |||
Dysplastic kidney | N/A | N/A | N/A | N/A | N/A |
MCDK is usually diagnosed by ultrasound examination before birth.
|
| ||||
Mesoblastic nephroma | + | + | - | + | - |
|
|
Classic mesoblastic nephroma
Cellular mesoblastic nephroma
Mixed mesoblastic nephroma
|
References
- ↑ Egas-Bejar D, Huh WW (2014). "Rhabdomyosarcoma in adolescent and young adult patients: current perspectives". Adolesc Health Med Ther. 5: 115–25. doi:10.2147/AHMT.S44582. PMC 4069040. PMID 24966711.
- ↑ Dasgupta R, Fuchs J, Rodeberg D (2016). "Rhabdomyosarcoma". Semin Pediatr Surg. 25 (5): 276–283. doi:10.1053/j.sempedsurg.2016.09.011. PMID 27955730.
- ↑ Park K, van Rijn R, McHugh K (2008). "The role of radiology in paediatric soft tissue sarcomas". Cancer Imaging. 8: 102–15. doi:10.1102/1470-7330.2008.0014. PMC 2365455. PMID 18442956.
- ↑ Shern JF, Yohe ME, Khan J (2015). "Pediatric Rhabdomyosarcoma". Crit Rev Oncog. 20 (3–4): 227–43. PMC 5486973. PMID 26349418.
- ↑ Hartman DS, Sanders RC (April 1982). "Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation". J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
- ↑ De Campo JF (1986). "Ultrasound of Wilms' tumor". Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
- ↑ Cahan LD (1985). "Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease". Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.
- ↑ Coppes MJ, Pritchard-Jones K (2000). "Principles of Wilms' tumor biology". Urol Clin North Am. 27 (3): 423–33, viii. PMID 10985142.
- ↑ Davidoff AM (2012). "Wilms tumor". Adv Pediatr. 59 (1): 247–67. doi:10.1016/j.yapd.2012.04.001. PMC 3589819. PMID 22789581.
- ↑ Burchill SA (2003). "Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities". J Clin Pathol. 56 (2): 96–102. PMC 1769883. PMID 12560386.
- ↑ Maygarden SJ, Askin FB, Siegal GP, Gilula LA, Schoppe J, Foulkes M; et al. (1993). "Ewing sarcoma of bone in infants and toddlers. A clinicopathologic report from the Intergroup Ewing's Study". Cancer. 71 (6): 2109–18. PMID 8443760.
- ↑ Panicek DM, Gatsonis C, Rosenthal DI, Seeger LL, Huvos AG, Moore SG; et al. (1997). "CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group". Radiology. 202 (1): 237–46. doi:10.1148/radiology.202.1.8988217. PMID 8988217.
- ↑ Grünewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E, Kovar H; et al. (2018). "Ewing sarcoma". Nat Rev Dis Primers. 4 (1): 5. doi:10.1038/s41572-018-0003-x. PMID 29977059.
- ↑ Lonergan GJ, Schwab CM, Suarez ES, Carlson CL (2002). "Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation". Radiographics. 22 (4): 911–34. doi:10.1148/radiographics.22.4.g02jl15911. PMID 12110723.
- ↑ Golden CB, Feusner JH (2002). "Malignant abdominal masses in children: quick guide to evaluation and diagnosis". Pediatr Clin North Am. 49 (6): 1369–92, viii. PMID 12580370.
- ↑ Angstman KB, Miser JS, Franz WB (1990). "Neuroblastoma". Am Fam Physician. 41 (1): 238–44. PMID 2403727.
- ↑ Musarella MA, Chan HS, DeBoer G, Gallie BL (1984). "Ocular involvement in neuroblastoma: prognostic implications". Ophthalmology. 91 (8): 936–40. PMID 6493702.
- ↑ Leung K, Stamm M, Raja A, Low G (2013). "Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging". AJR Am J Roentgenol. 200 (2): 370–8. doi:10.2214/AJR.12.9126. PMID 23345359.
- ↑ Stein PP, Black HR (1991). "A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience". Medicine (Baltimore). 70 (1): 46–66. PMID 1988766.
- ↑ Bravo EL (1991). "Pheochromocytoma: new concepts and future trends". Kidney Int. 40 (3): 544–56. PMID 1787652.
- ↑ Bravo EL (1991). "Pheochromocytoma: new concepts and future trends". Kidney Int. 40 (3): 544–56. PMID 1787652.
- ↑ Dorfman HD, Czerniak B (1995). "Bone cancers". Cancer. 75 (1 Suppl): 203–10. PMID 8000997.
- ↑ Burkitt lymphoma. MedlinePlus. https://www.nlm.nih.gov/medlineplus/ency/article/001308.htm Accessed on September 30, 2015
- ↑ Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L (2003). "Burkitt's lymphoma: new insights into molecular pathogenesis". J. Clin. Pathol. 56 (3): 188–92. PMC 1769902. PMID 12610094. Unknown parameter
|month=
ignored (help) - ↑ Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma